ASAP.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
ASAP.STAsarina Pharma AB (publ)	$0.03	-31.03%	$633959	—
ACE.STAscelia Pharma AB (publ)	$0.60	-3.22%	$80M	—
BIOA-B.STBioArctic AB	$318.00	+0.19%	$28.2B	—
BIOVIC-B.STBiovica International AB (publ)	$0.31	-0.65%	$85M	—
CANTA.STCantargia AB (publ)	$1.58	-0.06%	$445M	—
SPRINT.STSprint Bioscience AB	$2.90	+4.32%	$306M	—

Source: Financial Modeling Prep · peers by sector/industry

Asarina Pharma AB (publ)

Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research and development of pharmaceutical products. Their key therapeutic agent, Sepranolone, is developed to address menstrual migraine and Tourette syndrome. Founded in 2005, this Solna, Sweden-based company was previously known as Umecrine Mood AB before officially changing its name to Asarina Pharma AB (publ) in 2016.

www.asarinapharma.com

Employees: 5
IPO / List date: Sep 24, 2018
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds ASAP.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in ASAP.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded ASAP.ST yet.